SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic Evaluation of Pharmaceuticals
11 references·3 citing·45 second hop
Economic Evaluation of Pharmaceuticals (1993)Economic Evaluation of PharmaceuticalsMethods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential (1993)Standardizing Methodologies f…Guidelines for Economic Analysis of Pharmaceutical Products (1993)Guidelines for Economic Analy…Issues in the Cross-National Assessment of Health Technology (1992)Issues in the Cross-National …Economic Analysis as an Aid to Subsidisation Decisions (1992)Economic Analysis as an Aid t…Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status? (1992)Cost‐effectiveness guidelines…Cost-of-Illness Studies (1992)Cost-of-Illness StudiesEconomic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues (1991)Economic Analysis Alongside C…The use of QALYs in health care decision making (1989)The use of QALYs in health ca…Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents (1989)Quality-adjusted Life Years, …Cost-Benefit and Cost-Effectiveness Analysis in Health Care: Principles, Practice and Potential (1983)Cost-Benefit and Cost-Effecti…Economic evaluation of sevelamer in patients with end-stage renal disease (2007)Economic evaluation of sevela…A Structured Review of Studies on Health-Related Quality of Life and Economic Evaluation in Pediatric Acute Lymphoblastic Leukemia (2004)A Structured Review of Studie…Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe (1999)Current Trends in the Use of …Payment Restrictions for Prescription Drugs under Medicaid (1987)Clinical Economics (1989)Statistical Versus Quantitative Significance in the Socioeconomic Evaluation of Medicines (1994)The Use of Technology Assessment by Hospitals, Health Maintenance Organizations, and Third-Party Payers in the United States (1995)Information Created to Evade Reality (ICER) (2006)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)The Framing of Decisions and the Psychology of Choice (1981)Measurement of health state utilities for economic appraisal (1986)A review of the use of health status measures in economic evaluation. (1999)Incorporating societal concerns for fairness in numerical valuations of health programmes (1999)El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria (2001)Theory of Games and Economic Behavior (1945)Prospect Theory: An Analysis of Decision under Risk (1979)Prospect theory: An analysis of decision under risk (1988)Quality-of-Life Assessment: Can We Keep It Simple? (1992)Cost-utility analysis. (1993)Subjective Well-Being: Measuring Happiness, Suffering, and Other Dimensions of Experience (2013)Utilities and Quality-Adjusted Life Years (1989)A Clinician's Guide to Cost-Effectiveness Analysis (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Confidence intervals for cost/effectiveness ratios (1995)Cost-effectiveness of captopril therapy after myocardial infarction (1995)Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care. (1998)The Distinction Between Cost and Charges (1982)Meta-Analysis in Clinical Research (1987)Utility approach to measuring health-related quality of life (1987)Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods (1997)Introducing economic and quality of life measurements into clinical studies (2001)A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries (2004)Methods for the economic evaluation of health care programmes (1987)Assessing the costs of healthcare technologies in clinical trials. (1999)Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability (2005)Estimating the cost of illness. (1967)A Practical Guide for Calculating Indirect Costs of Disease (1996)Cost-of-illness studies of depression (2006)The Economic Burden of Personality Disorders in Mental Health Care (2008)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Economic analysis and clinical trials (1984)Estimating Costs in the Economic Evaluation of Medical Technologies (1990)National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma Care (1996)Qaly league tables: Handle with care (1993)Problems With the Interpretation of Pharmacoeconomic Analyses (2000)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1992Cost-of-Illness Studies489 cited
  • 1989Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents469 cited
  • 1989The use of QALYs in health care decision making374 cited
  • 1991Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues337 cited
  • 1993Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential230 cited
  • 1992Issues in the Cross-National Assessment of Health Technology160 cited
  • 1983Cost-Benefit and Cost-Effectiveness Analysis in Health Care: Principles, Practice and Potential158 cited
  • 1993Guidelines for Economic Analysis of Pharmaceutical Products142 cited
  • 1992Economic Analysis as an Aid to Subsidisation Decisions118 cited
  • 1992Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?86 cited

Cited by

  • 2007Economic evaluation of sevelamer in patients with end-stage renal disease77 cited
  • 2004A Structured Review of Studies on Health-Related Quality of Life and Economic Evaluation in Pediatric Acute Lymphoblastic Leukemia76 cited
  • 1999Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

74 cited